ClinicalTrials.gg
CompletedNCT03444441Updated Jan 19, 2021

Estimation of the Minimal Important Difference and Validation of Foot and Ankle Instruments

An observational study in Foot Diseases and Ankle Disease, sponsored by Helsinki University Central Hospital. Completed at 4 sites in Finland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-01-19.

Sponsored by Helsinki University Central Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
290
Ages
18 Years and older
Sex
All
01

Study summary

The present study investigates the minimal important change and validity of foot and ankle measures.

Read the detailed description

Patients who are waiting for foot and ankle surgery are recruited from four large referral centers (Peijas Hospital, Seinäjoki Central Hospital, Central Finland Central Hospital, Oulu University Hospital). Participants fill in foot and ankle-specific, generic and sosiodemographic questionnaires on the day of surgery, 6 months after surgery, and 6 months 2 weeks after surgery. Both pen-and-paper and electronic options for completing the questionnaire set are provided.

The data obtained from the Foot and ankle outcome score (FAOS), European foot and ankle society (EFAS) score, modified Lower extremity functional scale (LEFS), Visual analog scale foot and ankle (VAS-FA), Manchester Oxford foot and ankle (MOxFA) questionnaire, and the Foot and ankle ability measure (FAAM) are analyzed using the Rasch Measurement Theory and several other psychometric approaches to investigate minimal important change, reliability, responsiveness and validity of foot and ankle PRO instruments.

02

Conditions studied

  • Foot Diseases
  • Ankle Disease

Browse trials for

Keywords

  • Foot
  • Ankle
  • Finnish
  • Validation
  • FAOS
  • EFAS
  • LEFS
  • FAAM
  • VAS-FA
  • MOxFA
03

In context

Foot Diseases

47 studies on the registry are indexed under Foot Diseases; 9 are open to participants now.

Browse Foot Diseases studies →

Lead sponsor

Helsinki University Central Hospital is the lead sponsor of 311 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

The study recruits adult patients who are undergoing foot or ankle surgery for various reasons.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Full understanding of Finnish language
  • Undergoing foot or ankle surgery
  • At least 18 years old

Exclusion criteria

Exclusion Criteria:

  • Unbalanced mental disorder such as schizophrenia or depression
  • Age under 18
  • Does not understand Finnish
  • Undergoing operation other than foot or ankle
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
290 participants (actual)
Patient registry
No

Interventions

  • ProcedureFoot or ankle surgery

    Surgery for foot or ankle

    Also known as: correction forefoot, correction midfoot, correction hindfoot, correction ankle, combined correction, procedures for osteoarthritis foot or ankle, procedures for instability ankle, correction flatfoot, correction cavus foot, correction equinus foot, procedures for Diabetic ulcer, procedures for Charcot, procedures for tendinopathy Achilles, procedures for tendinopathy other, osteosynthesis, Other foot or ankle surgery

06

What researchers measure

Primary outcomes

  1. Minimal important difference

    Change from baseline scores at 6 months

    Time frame: Baseline, 6 months

Secondary outcomes

  1. Reliability

    Change from 6 months scores at 6.5 months

    Time frame: 6 months, 6.5 months

  2. General health question

    Change from baseline scores at 6 months

    Time frame: Baseline, 6 months

  3. General health question

    Change from baseline scores at 6 months

    Time frame: 6 months, 6.5 months

  4. Global assessment scale

    Change from baseline scores at 6 months

    Time frame: 6 months

  5. Validity

    Baseline scores

    Time frame: Baseline

  6. Validity

    6 months scores

    Time frame: 6 months

07

Study locations

4 sites
  • Central Finland Central Hospital
    Jyväskylä, Finland
  • Oulu University Hospital
    Oulu, Finland
  • Seinäjoki Central Hospital
    Seinäjoki, Finland
  • Peijas Hospital
    Vantaa, Finland
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2018 to primary completion in Mar 2019, 13 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 13, 2018
First posted
Feb 23, 2018
StartActual
Jan 15, 2018
Primary completionActual
Mar 6, 2019
CompletionActual
Mar 14, 2019
Last update
Jan 19, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 19, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03444441
Collaborators
Central Finland Hospital District, Seinajoki Central Hospital, Oulu University Hospital
Responsible party
Jussi Repo (Resident surgeon, Central Finland Hospital District) — Principal investigator
First posted
Feb 23, 2018
Start date
Jan 15, 2018
Primary completion
Mar 6, 2019
Completion
Mar 14, 2019
Last update
Jan 19, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion